Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
10/2005
10/20/2005WO2005070891A3 Compounds and methods of use
10/20/2005WO2005066129A3 Bis-pyridino containing compounds for use in the treatment of cns pathologies
10/20/2005WO2005030794B1 Hemiasterlin derivatives and uses thereof
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234096 Tetrahydroisoquinoline derivatives
10/20/2005US20050234044 Cyclic amine derivatives and methods of use
10/20/2005US20050234037 Compounds, compositions, and methods
10/20/2005US20050233234 Electroluminescent platinum compounds and devices made with such compounds
10/20/2005CA2561280A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
10/19/2005EP1586578A2 Method of removing allyl series protecting group using novel ruthenium complex and method of synthesizing allyl ethers
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005CN1683338A Process for preparing N-methyl quinoline codide compounds by ester reaction solvent
10/19/2005CN1683299A Metabolites of ecteinascidin 743
10/19/2005CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2004113277A3 Methods and compositions for treating amyloid-related diseases
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005CN1681498A Diaryl ethers as opioid receptor antagonist
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/06/2005WO2005092887A1 Compounds for the treatment of diseases
10/06/2005WO2005092841A1 Compounds having beta-agonist activity
10/06/2005WO2005092840A1 Formamide derivatives useful as adrenoceptor
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222222 1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxo-ethylamino]-1-oxo-propyl]-4-[bis-(4-fluorophenyl)methyl]piperazine; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222199 Process for the preparation of a hydrate of an antranilic acid derivative
10/06/2005US20050222139 Non-peptide gnrh antagonists
10/06/2005US20050222138 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
10/06/2005US20050222124 Benzenesulfonamide derivatives as antipsychotic agents
10/06/2005DE10361794B3 Optisch aktive heteroaromatische ß-Hydroxy-Ester und Verfahren zu deren Herstellung sowie deren Verwendung als Zwischenprodukte bei der Epothilon-Totalsynthese Optically active heteroaromatic beta-hydroxy ester, and processes for their preparation and their use as intermediates in the total synthesis of epothilone-
10/06/2005CA2560368A1 Compounds for the treatment of diseases
10/05/2005EP1581511A1 Ccr8 inhibitors
10/05/2005EP1581501A1 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as caspase inhibitors
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
09/2005
09/29/2005WO2005090292A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005090287A2 Phenylethanolamine derivatives as beta-2 agonists
09/29/2005WO2005089511A2 Novel pharmaceutical forms, and methods of making and using the same
09/29/2005US20050215590 Formamide derivatives for the treatment of diseases
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005CA2559203A1 Phenylethanolamine derivatives as beta-2 agonists
09/29/2005CA2554609A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1580187A1 Apoptogenic and antiproliferative analogs of ceramide
09/28/2005EP1243583B1 Heterocyclic compounds having sulfonamide groups
09/28/2005CN1675184A Caspase inhibitors and uses thereof
09/28/2005CN1675183A Acutumine and acutumine compound synthesis and use
09/27/2005US6949574 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
09/27/2005US6949567 Asymmetric amidine-substituted diphenylureas; diseases treated by the inhibition of intracellular protein degradation pathways, e.g. proteases, proteasome; anticarcinogenic agents; immunological modulators
09/27/2005US6949565 Protein kinase inhibitors
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/22/2005WO2005087743A1 Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors
09/22/2005WO2005087235A1 Pyrrolidine compounds
09/22/2005WO2005037208A3 Nitrone compounds prodrugs and pharmaceutical compositions of the same to treat human disorders
09/22/2005WO2005016876A3 Cyclic amine bace-1 inhibitors having a benzamide substituent
09/22/2005US20050209216 Inhibit the synthesis of TNF-alpha (TNF=tumor necrosis factor); use treating diseases linked to immune and inflammatory disorders or as analgesics; e.g. 7-(2-(4-(3-Trifluoromethylphenyl)piperazin-1-yl)ethyl)quinoline
09/21/2005EP1577291A1 Phenylethanolamine derivatives as beta-2 agonists
09/21/2005CN1671668A 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
09/21/2005CN1219770C Process for effectively purifying isoquinoline
09/20/2005US6946478 Compounds
09/15/2005WO2005067502A3 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
09/15/2005WO2005046578A3 Isoquinolinone potassium channel inhibitors
09/15/2005US20050203317 Removing the allyl group in a single reaction step with a high reaction rate and a high functional group selectivity without using any additive; cyclopentadienyl ruthenium (II) complex; catalytic dehydration type reaction of alcohols using the ruthenium complex
09/14/2005EP1572661A1 Crystalline form of quinapril hydrochloride and process for preparing the same
09/14/2005EP1572660A1 Isoquinolinone derivatives and their use as therapeutic agents
09/14/2005EP1572658A1 The use of 4-phenyl-substituted tetrahydroisoquinolines in the treatment of pain, migraine headaches and urinary incontinence
09/14/2005EP1572630A1 Antibacterial agents
09/14/2005CN1668721A Immunoadhesin comprising a glycoprotein VI domain
09/14/2005CN1668600A 5-substituted isoquinoline derivatives
09/13/2005US6943257 Low cost, minimizing environmental pollution, halogenation in presence of halodimethylsulfonium halide prepared in situ from halohydric acid and dimethylsulfoxide, as activated nucleophilic agent, one-pot process, bromination
09/13/2005US6943256 beta -diketimines that do not necessarily have asymmetric carbon atoms; Group IV metals, zirconium; polymerization catalysts; C2 symmetry
09/10/2005CA2500136A1 Method of removing allyl series protecting group using novel ruthenium complex and method of synthesizing allyl ethers
09/09/2005WO2005082858A2 Isoquinoline derivatives
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005WO2005048810A3 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors
09/09/2005CA2555720A1 Isoquinoline derivatives
09/08/2005US20050197362 Preventives/remedies for urinary disturbance
09/08/2005US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1569932A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP1366039B1 Piperazinylcarbonylquinolines and -isoquinolines
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005CN1665806A Medicine compound
09/07/2005CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
09/07/2005CN1665501A Novel compounds as opioid receptor modulators
09/07/2005CN1217936C Heterocyclic compounds having sulfonamide
09/07/2005CN1217932C Antibacterial agents
09/06/2005CA2217479C Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them
09/01/2005WO2005080361A1 Histamine-3 receptor modulators
09/01/2005WO2005080313A2 Sulfonamide derivatives for the treatment of diseases
09/01/2005US20050192297 melanocortin-4 receptor (MC4-R) agonists; antidiabetic agents; non-insulin dependent diabetes; obesity
09/01/2005US20050192281 Nitrone compounds, prodrugs and pharmaceuticals compositons of the same to treat human disorders
09/01/2005CA2555071A1 Histamine-3 receptor modulators
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 119